Antitumor effects of low-dose metronomic cyclophosphamide combined with Herceptin in orthotopic erbB2-overexpressing mammary tumors.

被引：0
|
作者：
Du Manoir, JM [1 ]
Viloria-Petit, A [1 ]
Man, S [1 ]
Mossoba, M [1 ]
Medin, JA [1 ]
Kerbel, RS [1 ]
机构：
[1] Univ Toronto, Dept Med Biophys, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6149S / 6149S
页数：1
相关论文
共 50 条
  • [1] Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water
    Man, S
    Bocci, G
    Francia, G
    Green, SK
    Jothy, S
    Hanahan, D
    Bohlen, P
    Hicklin, DJ
    Bergers, G
    Kerbel, RS
    CANCER RESEARCH, 2002, 62 (10) : 2731 - 2735
  • [2] Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
    Emmenegger, Urban
    Francia, Giulio
    Chow, Annabelle
    Shaked, Yuval
    Kouri, Andrew
    Man, Shan
    Kerbel, Robert S.
    NEOPLASIA, 2011, 13 (01): : 40 - 48
  • [3] Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models
    Daenen, Laura G.
    Shaked, Yuval
    Man, Shan
    Xu, Ping
    Voest, Emile E.
    Hoffman, Robert M.
    Chaplin, David J.
    Kerbel, Robert S.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (10) : 2872 - 2881
  • [4] Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer:: antitumor activity and biological effects
    Colleoni, M
    Orlando, L
    Sanna, G
    Rocca, A
    Maisonneuve, P
    Peruzzotti, G
    Ghisini, R
    Sandri, MT
    Zorzino, L
    Nolè, F
    Viale, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 232 - 238
  • [5] Rapamycin suppresses ErbB2-overexpressing mammary tumors through selective inhibition of luminal progenitor cells and tumor-initiating cells
    Zhao, Qingxia
    Parris, Amanda B.
    Howard, Erin W.
    Zhao, Ming
    Guo, Zhiying
    Xing, Ying
    Ma, Zhikun
    Yang, Xiaohe
    CANCER RESEARCH, 2017, 77
  • [6] Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy
    Shaked, Y
    Emmenegger, U
    Francia, G
    Chen, L
    Lee, CR
    Man, S
    Paraghamian, A
    Ben-David, Y
    Kerbel, RS
    CANCER RESEARCH, 2005, 65 (16) : 7045 - 7051
  • [7] Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
    Shiwen Peng
    Sofia Lyford-Pike
    Belinda Akpeng
    Annie Wu
    Chien-Fu Hung
    Drew Hannaman
    John R. Saunders
    T.-C. Wu
    Sara I. Pai
    Cancer Immunology, Immunotherapy, 2013, 62 : 171 - 182
  • [8] Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
    Peng, Shiwen
    Lyford-Pike, Sofia
    Akpeng, Belinda
    Wu, Annie
    Hung, Chien-Fu
    Hannaman, Drew
    Saunders, John R.
    Wu, T-C.
    Pai, Sara I.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (01) : 171 - 182
  • [9] A pilot pharmacokinetic and antiangiogenic biomarker study of celecoxib and low-dose metronomic vinblastine or cyclophosphamide in pediatric recurrent solid tumors
    Stempak, Diana
    Gammon, Janet
    Halton, Jacqueline
    Moghrabi, Albert
    Koren, Gideon
    Baruchel, Sylvain
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (11) : 720 - 728
  • [10] Clinical and Immunomodulatory Effects of Toceranib Combined with Low-Dose Cyclophosphamide in Dogs with Cancer
    Mitchell, L.
    Thamm, D. H.
    Biller, B. J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (02) : 355 - 362
12345